ProCE Banner Activity

Key Viral Hepatitis Studies From EASL 2022

Slideset Download
Conference Coverage
Read expert faculty members’ summaries of HBV, hepatitis delta virus (HDV), and HCV, including data on investigational HBV agents, progress toward HBV cure, emerging treatments for HDV, and HCV treatment implementation in treatment-experienced patients.

Released: July 06, 2022

Expiration: July 05, 2023

No longer available for credit.
Begin Activity

Share

Faculty

Tarik Asselah

Tarik Asselah, MD, PhD

Professor of Medicine
Department of Hepatology
Hôpital Beaujon
Université de Paris
Clichy, France

Stefan Zeuzem

Stefan Zeuzem, MD

Professor of Medicine
Chief, Department of Medicine
JW Goethe University Hospital
Frankfurt, Germany

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AbbVie

Gilead Sciences, Inc.

Faculty Disclosure

Primary Author

Tarik Asselah, MD, PhD

Professor of Medicine
Department of Hepatology
Hôpital Beaujon
Université de Paris
Clichy, France

Stefan Zeuzem, MD

Professor of Medicine
Chief, Department of Medicine
JW Goethe University Hospital
Frankfurt, Germany